Brendan Mooney Email

Head Engineering and Maintenance . BioCentriq

Current Roles

Employees:
95
Revenue:
$14.7M
About
BioCentriq was founded in 2018 and is a full service CDMO for cell and gene therapy process development and clinical manufacturing. Our ISO-7 certified GMP clinical manufacturing facility is in Newark, NJ. At this facility, we manufacture autologous and allogeneic cell therapies, gene therapies and provide analytical and quality services across several cell types. We offer viral vector production, cell and viral banking and upstream and downstream processing. Additionally, we have the capabilities to manufacture immunotherapies, including monoclonal antibodies and proteins, and vaccines. Our facilities provide full customer access to work in hybrid teams from tech transfer through GMP clinical production. BioCentriq has a BSL-2 certified process development facility located in South Brunswick, NJ to accelerate scale-up and translation activities. We are vendor and technology agnostic and work with our clients to leverage the optimal technology platform for your product through the development process. In support of our full suite of process development and clinical manufacturing services, the team at BioCentriq offers pre-defined and custom workforce development programs as well as full access to our centers during projects in a unique collaborative approach with our expert scientists to knowledge transfer. Learn more at www.biocentriq.com.
BioCentriq Address
138 Summit Street
Newark, NJ
United States
BioCentriq Email

Past Companies

BioCentriqHead of Engineering and Maintenance
HovioneDirector of Engineering and Maintenance
Eli Lilly and CompanyDirector of Plant Engineering

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.